Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
12
days
Autosomal‐Dominant Dystonia Associated with CAPN3 Variant
AuthorsYuan Gao; Dejiang Pang; Xiaokai Zhou; Yi Xiao; Qirui Jiang; Shichan Wang; Jiyong Liu; Yushan Tan; Qianqian Wei; Wei Song; Ruwei Ou; Xueping Chen; Chunyu Li; Jing Yang; Yiyuan Cui; Bi Zhao; Junyu Lin; Huifang Shang
Affiliations1. Department of Neurology, Rare Disease Center, Laboratory of Neurodegenerative Disorders West China Hospital, Sichuan University Chengdu China
90
days
Selectivity Filter KCND3 Variant Causes Spinocerebellar Ataxia 19/22 and K V 4 .3 Functional Loss
AuthorsChia‐Ju Lee; Kai‐Min Cheng; Wen‐Ling Cheng; Chang‐Heng Hsieh; Wei‐Tin Kuo; Shin‐Hung Pan; Chih‐Yung Tang; Chung‐Jiuan Jeng; Chin‐San Liu
Affiliations1. Department of Neurology Changhua Christian Hospital Changhua Taiwan; 2. Department of Physiology, College of Medicine National Taiwan University Taipei Taiwan; 3. Vascular and Genomic Center, Institute of ATP Changhua Christian Hospital Changhua Taiwan; 4. Institute of Anatomy and Cell Biology, College of Medicine National Yang Ming Chiao Tung University Taipei Taiwan; 5. Brain Research Center National Yang Ming Chiao Tung University Taipei Taiwan; 6. Graduate Institute of Integrated Medicine China Medical University Taichung Taiwan
82
days
Transcriptome‐Based Identification of ZZEF1 and ENTPD5 as Candidate Genes for Dystonia
AuthorsAlexandra Rudnik; Mirja Thomsen; Vicente A. Yépez; Ai Huey Tan; Frauke Hinrichs; Sebastian Loens; Shen‐Yang Lim; Yi Wen Tay; Thomas Musacchio; Sören Franzenburg; Tobias Bäumer; Marius Möller; Hauke Busch; Christine Klein; Norbert Brüggemann; Katja Lohmann
Affiliations1. Institute of Neurogenetics University Hospital Schleswig‐Holstein and University of Lübeck Lübeck Germany; 2. Institute for Human Genetics University Hospital Schleswig‐Holstein and University of Lübeck Lübeck Germany; 3. OmicsDiscoveries GmbH Planegg Germany; 4. Division of Neurology, Department of Medicine, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia; 5. Institute of Systems Motor Science, Center of Brain, Behavior and Metabolism University of Lübeck Lübeck Germany; 6. Department of Neurology University Hospital Würzburg Würzburg Germany; 7. Institute of Clinical Molecular Biology, University Hospital Schleswig‐Holstein and Christian‐Albrechts‐University of Kiel Kiel Germany; 8. Medical Systems Biology Division, Institute of Experimental Dermatology University of Lübeck Lübeck Germany; 9. Section of Movement Disorders, Department of Neurology University Hospital Schleswig‐Holstein Lübeck Germany
40
days
Rare‐Variant Burden in Mitochondrial Parkinson's Disease
AuthorsMartin Rakusa; Gaber Bergant; Borut Peterlin
Affiliations1. Division of Neurology University Medical Centre Maribor Maribor Slovenia; 2. Clinical Institute of Genomic Medicine University Medical Centre Ljubljana Ljubljana Slovenia
79
days
What Constitutes Long‐Duration Response?: From Withdrawal Studies to Virtual Trajectories in Parkinson's Disease
AuthorsHalil Onder
Affiliations1. Neurology Clinic Etlik City Hospital Ankara Turkey
65
days
Drug Repurposing for Parkinson's Disease Prevention: Replication Study of Three Drugs in French Healthcare Databases
AuthorsYanis Saidi; Anne Paakinaho; Eeva Pylkkö; Sirpa Hartikainen; Anna‐Maija Tolppanen; Alexis Elbaz; Ismaïl Ahmed; Anne C.M. Thiébaut; Émeline Courtois
Affiliations1. Université Paris‐Saclay, UVSQ, Inserm, Gustave Roussy, CESP, High‐Dimensional Biostatistics for Pharmacoepidemiology and Genomics Villejuif France; 2. School of Pharmacy, University of Eastern Finland Kuopio Finland; 3. Université Paris‐Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Exposome and Heredity Villejuif France
50
days
Joint Risk Factor Combinations with Additive Interaction Increase the Risk of Parkinson's Disease
AuthorsAndrea Quattrone; Basilio Vescio; Fulvia Arcuri; Giuseppe Chiarella; Jolanda Buonocore; Aldo Quattrone
Affiliations1. Institute of Neurology, Department of Medical and Surgical Sciences Magna Graecia University Catanzaro Italy; 2. Neuroscience Research Centre, Magna Graecia University Catanzaro Italy; 3. Department of Experimental and Clinical Medicine, Audiology Unit, Phoniatrics and Vestibology, Regional Center of Cochlear Implants and ENT Diseases Magna Graecia University Catanzaro Italy
4
days
Alkaline Phosphatases as a Potential Source of Variability in Foslevodopa Response: Muscles beyond Pharmacokinetics
AuthorsFabienne Ory‐Magne; David Devos; Guillaume Baille
Affiliations1. Department of Clinical Pharmacology and Neurosciences Toulouse Parkinson Expert Centre, INSERM UMR 1214 Toulouse France; 2. Department of Medical Pharmacology, University of Lille – Lille Neuroscience & Cognition Research Centre (LilNCog) INSERM U1172 University Hospital Centre Lille France; 3. Department of Neurology Foundation Rothschild Hospital Paris France
70
days
COVID ‐19 Amplifies Sex‐Specific Dopamine and Glial Responses in a Parkinson's Disease Mouse Model
AuthorsIfeoluwa Awogbindin; Mélanie Bourque; Marc Morissette; Marie‐Ève Hamelin; Chantal Rhéaume; Jared VanderZwaag; Antonia Landwehr; Disha Patel; Guy Boivin; Marie‐Ève Tremblay; Thérèse Di Paolo
Affiliations1. School of Medical Sciences, Faculty of Health University of Victoria Victoria British Columbia Canada; 2. Axe Neurosciences, Centre de recherche du CHU de Québec, Université Laval Québec Québec Canada; 3. Infectious Disease Research Center, Centre de recherche du CHU de Québec, Université Laval Québec Québec Canada; 4. Institute on Aging and Lifelong Health, University of Victoria Victoria British Columbia Canada; 5. Centre for Advanced Materials and Related Technology, University of Victoria Victoria British Columbia Canada; 6. Department of Biochemistry and Molecular Biology The University of British Columbia Vancouver British Columbia Canada
11
days
What Does α‐Syn‐ SAA ‐Negative Parkinson's Disease Reveal About the Proposed “Biological Definition” of Parkinson's Disease?
AuthorsAlberto J. Espay; Francisco Cardoso; Steven J. Frucht; Alberto Imarisio; Andrew J. Lees
Affiliations1. James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology University of Cincinnati Cincinnati Ohio USA; 2. Movement Disorders Unit, Neurology Service, Internal Medicine Department The Federal University of Minas Gerais Belo Horizonte Brazil; 3. The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders New York University Langone Health New York New York USA; 4. Department of Molecular Medicine University of Pavia Pavia Italy; 5. Neurogenetics Research Centre IRCCS Mondino Foundation Pavia Italy; 6. The National Hospital Queen Square and Reta Lila Weston Institute for Neurological Studies University College London London United Kingdom
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days